<DOC>
	<DOCNO>NCT01719029</DOCNO>
	<brief_summary>A good understanding optimal diet woman gestational diabetes fundamental management rapidly grow problem pregnancy . Careful comparison study current low- carbohydrate , higher-fat diet versus diet high complex carbohydrate lower fat critical order determine diet result favorable maternal 24-hour glucose , lipid , inflammatory profile , directly effect optimal fetal growth may influence future health offspring .</brief_summary>
	<brief_title>Role Macronutrient Diet Composition Infant Metabolic Outcomes Gestational Diabetes</brief_title>
	<detailed_description>Despite double prevalence gestational diabetes mellitus ( GDM ) last 10 year , dietary management guideline remain ambiguous due paucity randomize controlled trial . New diagnostic criterion recently develop diagnosis GDM expect increase prevalence 10-15 % pregnant woman . There grow recognition GDM long-term implication maternal risk diabetes intrauterine GDM environment independent risk factor childhood obesity impair glucose tolerance . Yet , diet use modify fetal fuel attenuate risk remain unknown human . Fundamental management GDM dietary intervention , yet historic practice advise low-carbohydrate ( CHO ) , higher-fat diet sufficiently test . Both animal non-human primate data support fetal programming influence maternal high-fat diet may promote insulin resistance , glucose intolerance , hepatic steatosis offspring . Recent human data suggest high maternal triglyceride ( TG ) free fatty acid ( FFA ) , variable sensitive dietary manipulation , independent risk factor fetal macrosomia adiposity . As result , consensus group abandon specific diet recommendation woman GDM . Despite pivotal role diet therapy treatment GDM , randomize trial directly compare glycemic lipoprotein profile conventional higher-fat diet diet . To address critical need , aim randomize cross-over trial study effect high complex carbohydrate/low-fat diet ( HC/LF ; 60 % CHO , 25 % fat , 15 % protein ) compare usual care , low-CHO/higher fat diet ( LC/HF ; 40 % CHO , 45 % fat , 15 % protein ) GDM woman : 1 ) 72-hour glycemic profile use continuous glucose monitoring system within subject ; 2 ) postprandial lipemia measure serial plasma TG FFA 5-hour , post-breakfast meal period within subject ; 3 ) maternal lipoprotein , inflammatory profile , in-vitro adipose tissue lipolysis 6-8 week diet therapy subject . We also measure neonatal adiposity air displacement plethysmography newborn marker lipid peroxidation , inflammation , dietary fat intake baby bear mother GDM . This pilot study directly test GDM diet effective limit maternal hyperglycemia hyperlipidemia randomize controlled fashion , potentially optimize fetal substrate availability fetal growth . Our goal determine diet intervention might favorably impact cycle could otherwise perpetuate future diabetes , obesity , CVD mother offspring .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>Inclusion Criteria . Potential participant â‰¥ 036 year old , include offspring pregnant mother GDM . Pregnant woman age 1840 year BMI 26 35 kg/m2 time diagnosis , singleton pregnancy , take medication GDM entrance study . Subjects diagnose GDM accord criterion establish ADA ACOG ( 19 ; 35 ; 53 ) , specifically , meet follow criterion : A 50gram Glucola one hour read &gt; 200 mg/dL FBG &gt; 95 mg/dL Two abnormal value 100gram 3 hour glucose tolerance test base Coustan Carpenter criterion adopt ADA Fourth International Workshop Gestational Diabetes ( 76 ; 77 ) : Fasting &gt; = 95 mg/dL &lt; 126 mg/dL 1 hr &gt; /= 180 mg/dL 2 hr &gt; /= 155 mg/dL 3 hr &gt; /=140 mg/dL Those woman overt diabetes suspect preexist diabetes follow criterion exclude , include : Fasting glucose &gt; 110 mg/dL , due high likelihood rapidly fail diet require medical treatment ( 35 ) . Random glucose &gt; 200 mg/dL Glycosylated hemoglobin A1C &gt; 6.5 NonEnglish speaking patient Fasting TG &gt; 400 mg/dL Women smoke exclude since lead cause low birth weight . In addition , woman risk factor placental insufficiency , include hypertension require betablocker treatment , renal disease , thrombophilias , preeclampsia , steroid use , history pancreatitis infectious disease hepatitis , intrauterine growth restriction exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>continuous glucose monitoring</keyword>
	<keyword>gestational diabetes</keyword>
	<keyword>diet therapy</keyword>
</DOC>